Edition:
India

Mithra Pharmaceuticals SA (MITRA.BR)

MITRA.BR on Brussels Stock Exchange

12.20EUR
19 Jan 2018
Change (% chg)

€0.62 (+5.35%)
Prev Close
€11.58
Open
€11.62
Day's High
€12.20
Day's Low
€11.58
Volume
176,981
Avg. Vol
34,262
52-wk High
€12.20
52-wk Low
€8.41

Select another date:

Wed, Dec 27 2017

BRIEF-Mithra Pharmaceuticals And Adamed Sign Commercialization Agreement For Myring™ In The Czech Republic

* MITHRA AND ADAMED SIGN COMMERCIALIZATION AGREEMENT FOR MYRING™ IN THE CZECH REPUBLIC

BRIEF-Mithra Pharmaceuticals Announces Injectables Agreement With GSP

* MITHRA CLOSES CONTRACTS WITH LEADING GENERICS PLAYER GSP FOR DEVELOPMENT AND SUPPLY OF 4 HORMONAL INJECTABLES

BRIEF-Mithra Pharmaceuticals Finalizes Estelle Contract With Libbs

* FINALIZES ESTELLE CONTRACT WITH BRAZILIAN WOMEN’S HEALTH LEADER LIBBS

BRIEF-Mithra Announces Valorization Of French Subsidiary

* SUCCESSFULLY DIVESTED ITS FRENCH AFFILIATE, MITHRA FRANCE‍​

BRIEF-Mithra Pharmaceuticals Announces Update On Clinical Study Progress For Estelle And Donesta‍​

* ANNOUNCES AN UPDATE ON THE CLINICAL STUDY PROGRESS FOR ESTELLE AND DONESTA‍​

BRIEF-Mithra Pharmaceuticals announces 36-month shelf life extension for Tibelia​

* ‍MITHRA ANNOUNCES 36-MONTH SHELF LIFE EXTENSION FOR TIBELIA​

BRIEF-Mithra Pharmaceuticals: ‍positive outcome of Myring commercial batch bioequivalence study​

* ‍POSITIVE OUTCOME OF MYRING COMMERCIAL BATCH BIOEQUIVALENCE STUDY

BRIEF-Mithra Pharmaceuticals ‍completes recruitment for Estelle Phase III study in US and Canada​

* ‍COMPLETES RECRUITMENT FOR ESTELLE® PHASE III STUDY IN US AND CANADA​

BRIEF-Mithra Pharmaceuticals' application for Tibelia marketing authorization accepted by Health Canada‍​

* MITHRA’S MARKETING AUTHORIZATION APPLICATION FOR TIBELIA ACCEPTED BY HEALTH CANADA‍​

BRIEF-Mithra Pharmaceuticals signs commercial agreement with Libbs

* MITHRA PHARMACEUTICALS SA - MITHRA SIGNS COMMERCIAL AGREEMENT WITH BRAZILIAN LEADER IN WOMEN’S HEALTH LIBBS FOR ESTELLE® IN BRAZIL

Select another date: